Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs

This publication has 58 references indexed in Scilit:

• Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis
  Journal of Biological Chemistry, 2006
• CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
  Annual Review of Pharmacology and Toxicology, 2005
• Establishment of N-Acetylmannosamine (ManNAc) Analogue-Resistant Cell Lines as Improved Hosts for Sialic Acid Engineering Applications
  Biotechnology Progress, 2004
• Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer
  Lung Cancer, 2004
• Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells
  Journal of Biological Chemistry, 2004
• Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms
  Proceedings of the Nutrition Society, 2003
• Transcription Factor ZBP-89 Cooperates with Histone Acetyltransferase p300 during Butyrate Activation of p21 Transcription in Human Cells
  Journal of Biological Chemistry, 2000
• Determining Cell Cycle Stages by Flow Cytometry
  Current Protocols in Cell Biology, 1999
• WAF1, a potential mediator of p53 tumor suppression
  Cell, 1993
• Pharmacokinetic Studies of N-Butyric Acid Mono- and Polyesters Derived from Monosaccharides
  Journal of Pharmaceutical Sciences, 1992